Molecular Mechanism of Local Drug Delivery with Paclitaxel-Eluting Membranes in Biliary and Pancreatic Cancer: New Application for an Old Drug

Molecular Mechanism of Local Drug Delivery with Paclitaxel-Eluting Membranes in Biliary and Pancreatic Cancer: New Application for an Old Drug

Implantation of self-expanding metal stents (SEMS) is palliation for patients suffering from inoperable malignant obstructions associated with biliary and pancreatic cancers. Chemotherapeutic agent-eluting stents have been developed because SEMS are susceptible to occlusion by tumor in-growth. We re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sookhee Bang, Sung Ill Jang, Su Yeon Lee, Yi-Yong Baek, Jieun Yun, Soo Jin Oh, Chang Woo Lee, Eun Ae Jo, Kun Na, Sugeun Yang, Don Haeng Lee, Dong Ki Lee
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2015/568981
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅰ: Drug transport
by: Tuoi Vo, et al.
Published: (2017-03-01)

Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅱ: Cell proliferation
by: Adam Peddle, et al.
Published: (2018-09-01)

Patient Safety Events Related to the Placement of Drug-Eluting Stents
by: Patient Safety Authority
Published: (2023-12-01)

Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes Based on the Hemoglobin A1c Level
by: Yong Hoon Kim, et al.
Published: (2020-01-01)

A model of competing saturable kinetic processes with application to thepharmacokinetics of the anticancer drug paclitaxel
by: Rebeccah E. Marsh, et al.
Published: (2011-03-01)

Peripheral Artery Disease Intervention: Drug-Coated Balloon vs Drug-Eluting Stent, A Long-Term Comparison
by: Nathan Marzlin, et al.
Published: (2022-01-01)

Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies
by: Robert J. Gil, et al.
Published: (2020-01-01)

Safety and Efficacy of Second-Generation Drug-Eluting Stents in Real-World Practice: Insights from the Multicenter Grand-DES Registry
by: You-Jeong Ki, et al.
Published: (2020-01-01)

Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer
by: Jiabing Wang, et al.
Published: (2023-01-01)

A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
by: Adriana Toro, et al.
Published: (2015-01-01)

Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents
by: Amir F. Mohani, et al.
Published: (2018-01-01)

Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR
by: Zhongxia Wang, et al.
Published: (2016-01-01)

Development and evaluation of drugs : from laboratory through licensure to market /
by: Lee, Chi-Jen
Published: (2003)

Advantages and disadvantages of coronary drug-eluting stent: a 23-year journey of randomized clinical trials
by: Alfredo E. Rodriguez, et al.
Published: (2024-07-01)

Corrigendum to “Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR”
by: Zhongxia Wang, et al.
Published: (2019-01-01)

Conventional and drug‑eluting bead transarterial chemoembolization in patients with inoperable intrahepatic cholangiocarcinoma: a meta‑analysis
by: Su-Rong Pan, et al.
Published: (2024-11-01)

Comparison of biodegradable and durable polymer drug-eluting stents in acute coronary syndrome: a meta-analysis
by: Tingting Wei, et al.
Published: (2022-06-01)

Automated Subfield Volumetric Analysis of Hippocampus in Patients with Drug-Naïve Nondementia Parkinson’s Disease
by: Jin-Woo Park, et al.
Published: (2019-01-01)

A comparison of drug‐eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure
by: Kun Wang, et al.
Published: (2022-06-01)

Clinical Outcomes of Drug-Eluting Bead Transarterial Chemoembolization Loaded with Raltitrexed for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
by: Yonghua Bi, et al.
Published: (2022-01-01)

Drug-Coated versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated with Provisional Stenting Using Drug-Eluting Stents: A Meta-analysis
by: Zhi-Ming Jiang, et al.
Published: (2022-01-01)

Rab21-Targeted Nano Drug Delivery System-Based FFPG for Efficient Paclitaxel Delivery to Inhibit Lung Cancer Progression
by: Jing Wang, et al.
Published: (2025-01-01)

Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
by: Nicolas W. Shammas, et al.
Published: (2013-01-01)

Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study
by: Kyle Murnaghan, et al.
Published: (2022-01-01)

Low Resolution Limits and Inaccurate Algorithms Decrease Significantly the Value of Late Loss in Current Drug-Eluting Stent Trials
by: Johannes B. Dahm, et al.
Published: (2012-01-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01)

Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation
by: Liu Haibo, et al.
Published: (2014-01-01)

A Review of the Physiological and Immunological Functions of Biliary Epithelial Cells: Targets for Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis and Drug-induced Ductopenias
by: Chih-Te Wu, et al.
Published: (2004-01-01)

Recent Progress of Genome Study for Anaplastic Thyroid Cancer
by: Jieun Lee, et al.
Published: (2013-06-01)

Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis
by: Chun Shing Kwok, et al.
Published: (2014-01-01)

Construction of an Integrated Positive Youth Development Conceptual Framework for the Prevention of the Use of Psychotropic Drugs among Adolescents
by: Tak Yan Lee
Published: (2011-01-01)

Effect of bicarbonate buffer on artificial membrane permeation of drugs
by: Shiori Ishida, et al.
Published: (2025-01-01)

Half-Metallic Ferromagnetism in Chalcopyrite (AlGaMn)P2 Alloys
by: Byung-Sub Kang, et al.
Published: (2015-01-01)

Clinical Effects of Activated Charcoal Unavailability on Treatment Outcomes for Oral Drug Poisoned Patients
by: Sohyun Park, et al.
Published: (2018-01-01)

Prominent Naturally Derived Oxidative-Stress-Targeting Drugs and Their Applications in Cancer Treatment
by: Eunsun Lee, et al.
Published: (2025-01-01)

Experimental Study on the Structural Performance Degradation of Corrosion-Damaged Reinforced Concrete Beams
by: Ju-Seong Jung, et al.
Published: (2019-01-01)

Effect of self-healing of cracks in chloride ion diffusion and corrosion of engineered cementitious composites
by: Abel Shiferaw Alemu, et al.
Published: (2025-03-01)

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
by: Juan Wang, et al.
Published: (2025-01-01)

Genetic Variations of Gene Associated with Adverse Drug Reactions to Valproic Acid in Korean Epileptic Patients
by: Ji Hyun Yi, et al.
Published: (2013-12-01)

Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer
by: Kyong-Ah Yoon, et al.
Published: (2018-12-01)